Weeks 9 to 12: dose-dependent acceleration By weeks 9-12, people on higher doses (8mg or transitioning to 12mg) typically experience the strongest appetite suppression they have felt to date
At present, WW doesnt offer compounded medications to navigate this issue
But, law of large numbers (~1800 patients) says the probablility of meaningful imbalance in T2D patient fractions in trial arms is slim
Older adults (where sarcopenia compounds the effect), people starting with lower muscle mass, anyone eating very little protein, and those doing no resistance training
The best way to keep patients safe is education and communication
For example, we deeply appreciate it when a company subjects its products to third-party testing, but not all companies make the results of that testing available